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1. INTRODUCTION 
1.1. POTASSIUM CHANNEL KV7.2 
During this Bachelor’s Final Work, the voltage-dependent potassium channel Kv7.2 
was studied. This channel is primarily located in nervous system cells where together 
with Kv7.3 channel subunits, forms heteromeric channels responsible for the M 
current (Otto et. al., 2006). 
The M current is a neuronal excitability regulatory current that avoids the repetitive 
firing of action potentials. Kv7.2 channels open after the firing of an action potential 
allowing potassium ions to flow out of the cell. This potassium movement turns the 
membrane potential more negative, bringing the membrane back to the resting 
potential and making it more difficult to fire new action potentials. 
As Chung (2014) indicated, Kv7.2 channels form tetramers where each subunit 
consists of 6 transmembrane domains (S1-S6) and an intracellular C-terminal tail 
composed of 4 helices (A-D) (Figure 1). The S5 and S6 domains form the pore, while 
the intracellular helices are very important for the regulation of channel activity though 
interaction with different regulatory molecules. 
 
Figure 1. Structure of the potassium channel Kv7.2. The channel contains six transmembrane domains (S1-
S6) and four intracellular helices (A-D). The interaction of Calmodulin (CaM) with helices A and B is crucial for 
channel function. Adapted from Chung (2014). 
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Among the different molecules implicated in channel regulation, the interaction of 
Calmodulin (CaM) with the channel is of particular importance. Calmodulin is a 
calcium sensing protein, that mediates Kv7.2 regulation by Ca2+ ions through CaM 
interaction with the channel cytosolic A and B helices. The subsequent binding of 
calcium ions provokes a conformation change in Calmodulin, which leads to a 
reorientation of helices A and B promoting channel closure and the subsequent M 
current inhibition (Bernardo-Seisdedos et. al., 2018). Additionally, Calmodulin assists 
in the trafficking of Kv7.2 to the cell membrane. When the CaM-Kv7.2 binding sites 
were mutated, the surface expression of the channel was reduced, and Kv7.2 
accumulated in the endoplasmic reticulum (Alaimo et. al., 2009). All in all, 
Calmodulin interaction is necessary for the good functioning of potassium channel 
Kv7.2. 
A proper functioning of Kv7.2 is essential for the regulation of neuronal excitability. 
In fact, mutations in this channel have been described to provoke serious epileptic 
diseases such as Benign Familiar Neonatal Convulsions (Goldberg-Stern et al., 2009), 
Rolandic epilepsy (Neubauer et. al., 2008) or epileptic encephalopathy (Weckhuysen 
et. al., 2012). The study of the structure and regulation of the potassium channel Kv7.2 
is paramount in order to treat those diseases. 
1.2. COTRANSLATIONAL FOLDING 
The term “cotranslational folding” refers to the folding of a protein while it is being 
translated in the ribosome.  Those first instants in which the nascent chain starts folding 
are crucial for the final configuration of the protein. 
Most of our current understanding about protein folding comes from in vitro 
experimental approaches where folding is usually studied from purified and afterwards 
denatured proteins. These methods, however, substantially differ from the in vivo 
folding process, where nascent polypeptidic chains are synthesized and usually 
cotranslationally folded in the ribosome under complex physiological conditions. In 
order to approach protein folding from a more biological point of view, different 
technics have been developed including high resolution structural methods or the use 
of arrest peptides. 
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The structure of the potassium channel Kv7.2 has been well described, but its 
cotranslational folding has received little attention. Cotranslational protein misfolding 
could  be responsible for some of the epileptic diseases caused by mutations in the 
Kv7.2 channel. Particularly, there is the suspicion that the mutant W344R, an epilepsy-
causing Kv7.2 inactive variant harboring a tryptophan by arginine substitution in the 
protein helix A, could undergo some cotranslational misfolding. To decipher if this is 
the case, first the cotranslational folding of wild-type helices A and B must be studied. 
To this aim, in this work the so-called arrest peptides (APs) were used for in vivo 
protein cotranslational folding studies. 
1.3. ARREST PEPTIDES 
Arrest peptides are gene expression regulator sequences that interact specifically with 
the ribosome exit tunnel, arresting the translation of the nascent peptide. The most 
widely known arrest peptide is the one encoded by SecM. SecM is a prokaryotic 
periplasmic protein containing an arrest peptide which regulates the levels of the 
cotranscribed translocation motor protein SecA (Butkus et. al., 2003). Owing to the 
interaction of the arrest peptide with the ribosome exit tunnel, the A-site and P-site of 
the ribosome are altered causing the stalling of the translation (Zhang et. al., 2015). 
If the arrest peptide stalls the translation, the following amino acids are not 
synthesized, so a shorter, truncated version of the protein is produced (Nakatogawa & 
Ito, 2001). In contrast, in the absence of translation arrest, the full-length protein will 
be synthesized.  
There is a key aspect in this technique. If a force is exerted outward of the ribosome 
while the arresting peptide is interacting with the ribosome exit tunnel, that pulling 
force relieves the stall of the translation. This relief allows the translation to continue, 
so the full-length protein is synthesized (Ismail et. al., 2012). That force can be 
generated when the nascent polypeptide emerges and folds in close proximity to the 
ribosome exit tunnel. The protein folding generates a force that can relieve the stall of 
the translation (Figure 2). 
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Figure 2. Relief of the arrest peptide stalling. A) If there is no folding force acting when the arrest peptide 
interacts with the ribosome exit tunnel, the translation is stalled. B)  If the protein folds at the exact point in which 
the arrest peptide is interacting with the ribosome exit tunnel, the force generated by protein folding can relieve the 
stall of the translation. Adapted from Goldman et. al. (2015). 
In this work, the pulling force will be caused by the folding of helices A and B. Folding 
has to take place exactly when the arrest peptide is interacting with the ribosome exit 
tunnel in order to relieve the stall and produce the full-length protein. If folding takes 
place earlier or later than the moment when the arrest peptide sequence interacts with 
the ribosome exit tunnel, the stall will not be relieved and a truncated form of the 
protein will be produced.   
Hence, arrest peptides can be used as  “in vivo force sensors” (Cymer & von Heijne, 
2013). Comparison of full-length and truncated protein fractions will provide 
information about in vivo protein folding, as it will indicate if the helices are 
cotranslationally folded. 
2. OBJECTIVES 
The goal of this work is to study the cotranslational folding of Kv7.2 cytosolic A and 
B helices. It has been hypothesized that the epilepsy-causing mutant W344R (or even 
other mutants) could undergo some form of cotranslational misfolding. In this project, 
we aim to establish an arrest peptide-based method that in the future allows studying 
the in vivo cotranslational folding of those epileptic variants. 
Hence, the objective of the work is twofold: 
1) To test the use of arrest peptides as a technique to study cotranslational folding. 
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2) To determine if the A and B helices are cotranslationally folded in the ribosome 
vestibule. 
3. MATERIALS AND METHODS 
3.1. CONSTRUCTS USED IN THIS WORK 
In order to study the in vivo folding of Kv7.2 cytosolic A and B helices, the designed 
constructs were composed by an arrest peptide separated from the AB helices by a 
variable-length linker and flanked by reporter mTFP1 and mcpVenus173 fluorescent 
proteins in the N- and C-terminal ends respectively (Figure 3).  
Figure 3. Constructs used in this work. 5 constructs were designed with different linker length, varying the amino 
acid number between Helix B and the arrest peptide (AP). The fluorescence of mTFP1 will account for the total 
protein, whereas the fluorescence of mcpVenus173 will account for the full-length protein. 
The linker length is of especial importance for protein translation arrest efficiency. If 
the linker is too short, the protein will still be confined inside the ribosome exit tunnel, 
so it will not be able to fold. In the absence of folding force, translation will be stalled. 
If the linker is adequate (linkers with an intermediate length), the protein will fold in 
the ribosome vestibule, at the exact point in which the arrest peptide is interacting with 
the ribosome exit tunnel, thereby relieving the stall. Finally, if the linker is too long, 
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the protein will already be folded by the time the arrest peptide starts interacting with 
the ribosome exit tunnel, so the translation will be stalled (Figure 4). 
Figure 4. Importance of the linker length. The arrest peptide is depicted in blue, the linker in black and the protein 
in red. A) If the linker is too short, the protein will still be inside the ribosome exit tunnel. As protein folding does 
not occur in such a confined space, the arrest peptide stalls the translation. B) If the linker is adequate, the protein 
will fold at the exact point in which the arrest peptide is interacting with the ribosome exit tunnel, generating a force 
that relieves the stall. C) If the linker is too long, the protein will be already folded by the time the arrest peptide 
interacts with the ribosome exit tunnel. As the folding force will not be transmitted to the arrest peptide in the 
appropriate moment, protein translation will be stalled. Adapted from Farias-Rico et. al. (2018). 
Due to its impact on protein translation arrest, a 49 residue-long linker containing 
restriction enzyme sites was used as template to obtain linkers of 21, 26, 33 and 39 
residues long. The arrest peptide sequence length was included in the length of the 
linkers (Figure 3). 
Fluorescent proteins were used in order to quantify the full-length and truncated 
protein fractions. mTFP1 and mcpVenus173 fluorescent proteins were located at the 
construct N and C-terminus respectively (Figure 3), so the truncated version will not 
have mcpVenus173. Therefore, mcpVenus173 will account for the full-length peptide 
while mTFP1 will be present both in the full-length and in the truncated protein forms, 
so it will indicate the total protein.  
3.2. MOLECULAR CLONING 
3.2.1. Vectors 
The constructs containing AB helices with variable linker lengths were already cloned 
in the pProEx-HT C vector for further protein expression. However, it was very useful 
to clone them in a pET expression system in order to have a more restrictive and 
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controlled protein expression. The chosen vector was pET-14b. The most important 
characteristic of pET vectors is the presence of a T7 promoter. Therefore, in order to 
express the construct, the bacteria used must contain a copy of the T7 RNA polymerase 
gene inducible by IPTG. Escherichia coli BL21(DE3)plysS strain was used for 
expression. These cells contain a DE3 lysogen that carries the T7 RNA polymerase 
gene. IPTG is required to induce polymerase expression and further expression of the 
genes cloned downstream the T7 promoter. 
Another important feature is the ampicillin resistance gene, which allows the selection 
of positive colonies through ampicillin. 
 
Figure 5. Features of the pET-14b vector. Adapted from Novagen manuals (Merck). 
3.2.2. Digestions and ligations 
In order to transfer the L49 construct from pProEx-HT C to pET-14b, restriction 
enzyme digestion was carried out. It was necessary to choose two enzymes that cut 
before and after the construct in pProEx-HT C, but also had to be present in the pET-
14b polylinker, in the correct orientation. The restriction enzymes utilized were Nco I 
and Xho I. The protocol employed is described in Table 1.  
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Table 1. Protocol employed for DNA digestions. The enzymes and Tango Buffer were bought from Thermo 
Fischer Scientific. 4 μL of Tango Buffer 10X were added in order to reach a final concentration of 2X. 
DNA (1 
μg/μL) 
Enzyme 1 
(10 U/μL) 
Enzyme 2 (10 
U/μL) 
Tango 
Buffer 
(10X) 
Milli-Q 
H2O 
Final 
volume 
Temperature Time 
1 μL 0.5 μL 0.5 μL 4 μL 14 μL 20 μL 37ºC 3 h 
First, both the L49 construct in pProEx-HT C and the empty vector pET-14b were 
digested with Nco I and Xho I following the protocol (Table 1). The digestion was 
neutralized by adding 2 μL of Loading Buffer (50% glycerol, 0.2 M EDTA, 0.05% 
bromophenol blue, pH 8) and loaded in an agarose gel 1% (w/v), using TBE as buffer 
(45 mM Tris-Borate, 1 mM EDTA, pH 8). Gels were stained with GelRedTM Nucleic 
Acid (Thermo Fischer Scientific). As DNA length marker, λ DNA digested with 
BstEII was used. 
Agarose gels were run for approximately 40 minutes at 120 V. Afterwards, the bands 
corresponding to the desired vector and fragment (construct) were excised from the 
gel and the DNA was purified with a DNA extraction kit (GeneJET Gel Extraction 
Kit, Thermo Fischer Scientific) according to the manufacturer’s instructions. 
Finally, the purified vector and construct were ligated with T4 DNA ligase (Thermo 
Fischer Scientific). A mixture was prepared with 7.5 μL DNA fragment, 1 μL of vector 
DNA, 1 μL of ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 1 mM ATP, 10 mM 
DTT, pH 7.5) and 0.5 μL of T4 DNA ligase. Ligation was performed overnight at room 
temperature. 
3.2.3. Bacterial transformation 
For cloning, Escherichia coli BSJ strain was used, because it grows quickly. Bacterial 
transformation was carried out by chemical transformation. The process was executed 
in sterile conditions. First, 100 μL of chemo-competent bacteria (treated with CaCl2) 
were thawed on ice. Then, a mixture was prepared with 45 μL of transformation buffer 
(22 mM MgCl2 and 11 mM CaCl2), 5 μL of ligate and 100 μL of bacteria. The mixture 
was first incubated 20 minutes on ice, and then 10 minutes at room temperature. 
Afterwards, to help cells recover from the shock, bacteria were incubated in Luria-
9 
 
Bertani (LB) growth medium at 37 ºC for 45 minutes. Next, cells were harvested by 
centrifugation, and seeded into LB-agar plates with ampicillin. Plates were incubated 
at 37ºC overnight. 
3.2.4. DNA extraction 
After cell growing in LB-agar plates, single colonies were picked and grown overnight 
at 37ºC in 3 mL of LB growth medium with ampicillin. 2 mL of this culture were used 
for DNA extraction, while the other mL was stored as a stock in case the procedure 
had to be repeated. The cells were harvested from those 2 mL by centrifugation, and 
the bacterial pellet was resuspended in 150 μL of Tris-EDTA (10 mM:1 mM, pH 8). 
Then, 150 μL of lysis solution (0.2 M NaOH and 1% SDS) were added and mixed, 
followed by the addition of 150 μL of neutralization salts (3 M AcK+ and 5 M AcH). 
After adding 80 μL of phenol/chloroform (1:1) and vortexing, the tubes were 
centrifuged. This centrifugation with phenol/chloroform causes lipids to precipitate, 
proteins to stay in the interphase between pellet and supernatant, and plasmid DNA 
and RNA to stay soluble in the supernatant. The supernatant was mixed with 200 μL 
of isopropanol, which causes nucleic acids to precipitate. After centrifugation, the 
supernatant was discarded and the DNA pellet was resuspended in 30 μL of Tris-
EDTA with RNase. This will be the final purified vector DNA, with an approximate 
concentration of 1 μg/μL. 
In order to prepare the aforementioned stock, 700 μL of bacteria were mixed with 300 
μL of glycerol 50%. The bacterial stock was stored at -80ºC. 
3.2.5. DNA checking 
After extraction, the DNA was checked in order to make sure that the purified DNA 
was the desired one, and not the parental DNA (in this case, the construct in pProEx-
HT C) or contamination. With this goal, the purified DNAs were digested with Bgl II 
and Xho I and analyzed by agarose gel electrophoresis as described before (3.2.2. 
Digestions and ligations). The Bgl II site is present in pET-14b, but absent in pProEx-
HT C, so this checking will be further proof that the construct has been correctly 
inserted in pET-14b. 
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The digestions were carried out as described before, except that 0.2 μL of enzymes 
were used (instead of 0.5 μL) and the digestion time was 2 hours (instead of 3 hours).  
3.2.6. Linker deletions 
Once the L49 construct was inserted and checked in pET-14b, linker deletions were 
executed to obtain linker lengths of  39 (L39), 33 (L33), 26 (L26) and 21 (L21) residues 
long. The deletions were carried out as described before (3.2.2. Digestions and 
ligations) using the following restriction enzyme pairs: Eco 72I (L39), Sna BI /Stu I 
(L33), Sma I /Eco 72I (L26) and Sna BI /Eco 72 I (L21). 
Once the digestion was completed, the same cloning procedure was repeated for each 
linker length. They all were run in an agarose gel, ligated (recircularized, in this case), 
and transformed in E. coli BSJ for DNA extraction and subsequent checking). 
3.2.7. DNA Sequencing 
In order to absolutely check that the constructs had been successfully cloned in pET-
14b, DNA sequencing was carried out following the Sanger sequencing method. 
Samples containing 1.5 μL of the desired primer at a concentration of 100 μM, 1.5 μL 
of DNA at an approximate concentration of 1 μg/ μL (reaching a final concentration 
of 0.1 μg/ μL) and 12 μL of H2O were sent to the Secugen sequencing company. The 
primer used in this work hybridizes with the final nucleotides corresponding to 
mTFP1. Thus, the helices and linker were sequenced. 
Upon the reception of the sequencing result, the obtained sequence was compared with 
the expected one using the BLASTn alignment tool (Madden, 2002). 
3.3. PROTEIN EXPRESSION 
3.3.1. Bacterial transformation 
For protein expression, E. coli BL21(DE3)plysS strain was used. BL21 are well-
known to express heterologous genes, while DE3 means that the strain has the T7 RNA 
polymerase inducible by IPTG, which is necessary to express pET vectors. plysS is a 
plasmid that expresses low levels of T7 lysozyme, an inhibitor of T7 RNA polymerase. 
Hence, the background expression of the target genes is inhibited. When adding IPTG, 
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however, big amounts of T7 RNA polymerase are produced, much more than what T7 
lysozyme can inhibit, so target genes will be expressed without problems. 
The transformation procedure was exactly the same as the one described in section 
3.2.3. Bacterial transformation. The only difference was that, in this case, 0.5 μL of 
DNA were used (instead of 5 μL of ligate in section 3.2.3.), because the extracted DNA 
is much more concentrated than the ligate obtained in section 3.2.2. 
3.3.2. Cell growth and protein expression 
Two colonies were picked from every plate, and each colony was grown in 10 mL of 
LB growth medium with ampicillin. The cultures were incubated at 37ºC until the 
optical density, measured with the spectrophotometer Jenway 6300, reached 0.6 at 600 
nm. At this point, cells are expected to be in the exponential growth phase, which is 
ideal for gene expression. Gene expression was induced by adding IPTG to a final 
concentration of 0.5 mM, in order to produce T7 RNA polymerase and express the 
constructs. After 3 hours of gene expression at 37ºC, cells were harvested by 
centrifugation. 
3.3.3. Cell homogenization 
The bacterial pellet was resuspended in 500 μL of buffer 120 mM KCl, 5 mM NaCl, 
50 mM HEPES pH 7.4, 5 mM EGTA, 1 mM DTT and protease inhibitor. Cells were 
lysed by sonication, using the Soniprep 150 MSE (SANYO) equipment. 5 sonication 
cycles were used, each cycle with 3 seconds of activity, 5 seconds of rest and an 
amplitude of 7.5. The lysate was centrifuged for 10 minutes at 13,000 g to separate the 
soluble fraction from cellular debris.  
3.3.4. Polyacrylamide gel electrophoresis 
Protein expression was then analyzed by SDS-PAGE electrophoresis. For that 
purpose, 10% SDS-polyacrylamide gels of 1 mm thickness were prepared. For sample 
preparation 20 μL of each soluble fraction was mixed with 5 μL of electrophoresis 
loading buffer (62.5 mM Tris-HCl, 20% glycerol, 2% SDS, 5% β-mercaptoethanol, 
0.05% bromophenol blue, pH 6.8). 15 μL of the mixture of each sample were loaded 
into the gel. Gels were run with electrophoresis buffer (25 mM Tris-HCl, 192 mM 
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glycine, 0.1% SDS, pH 8.3) at 120 V until the bromophenol blue reached the end of 
the gel. As molecular mass marker Protein Marker VI (PanReac AppliChem) was used. 
Finally, the gels were visualized using the VersaDoc 4000 (BioRad) image system. 
First, the gels were excited at 488 nm, in order to excite the mTFP1 and see both full-
length and truncated protein bands. Then, the gels were excited at 555 nm, in order to 
excite mcpVenus173 and observe the full-length protein bands. 
3.3.5. Fluorometric assay 
The fluorometric assays were carried out in a FluoroMax-3 (Horiba) fluorometer. 
Quartz cuvettes with a path length of 3 cm and a volume of 100 μL were used. For 
each linker length, 100 μL of the soluble sample were used to measure the emission 
spectra of mTFP1 and mcpVenus173 fluorescent proteins upon excitation at 458 and 
515 nm respectively. mTFP1 emission spectrum was recorded at 470-570 nm while 
mcpVenus173 emission was monitored at 520-570 nm. 
The ratio of full length (FL)/total protein was calculated as follows and used as an 
indicator of “in vivo” protein folding:  
 Ratio FL/total protein =
Fluorescence at 528 nm when exciting at 515 nm
Fluorescence at 492 nm when exciting at 458 nm
                    (1)       
where 492 is the peak emission wavelength of mTFP1, while 528 is the peak emission 
wavelength of mcpVenus173.  
4. RESULTS 
4.1. MOLECULAR CLONING 
4.1.1. L49 construct 
4.1.1.1. Digestion 
First, it was necessary to insert the construct having the 49 residue-long linker in the 
pET-14b vector. As this construct was already cloned in a pProEx plasmid, both the 
empty pET-14b vector and the construct-containing pProEx plasmid were digested 
with Nco I and Xho I restriction enzymes. The empty pET-14b vector has a total length 
of 4671 bp. After digestion, it was expected to release fragments of 65 and 4606 bp. 
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The pProEx vector containing the sequence of interest has a total length of 6517 bp, 
and fragments of 1910 and 4607 bp were expected. The 1910 bp fragment is the L49 
construct, which was later inserted in pET-14b. 
Figure 6. Digestion of the empty pET-14b vector and the L49 construct-containing pProEx vector. A) λ DNA 
digested with BstEII used as DNA molecular marker. Adapted from SibEnzyme webpage. B) 1x agarose gel with 
the empty pET-14b and the pProEx vector containing the L49 construct, digested with Nco I and Xho I. The gel 
was run for 50 minutes at 120 V. Lane 1: λ DNA digested with BstEII used as DNA molecular marker. Lane 2: pET-
14b digested with Nco I and Xho I. Lane 3: L49 construct in pProEx digested with Nco I and Xho I. 
As shown in Figure 6, the expected fragment lengths were obtained. The 65 bp 
fragment of pET-14b is not observed because, as it is very small, its electrophoretic 
mobility is very high and it runs out of the gel. To follow with the cloning process, the 
4606 bp fragment of pET-14b was excised and purified. On the other hand, the 1910 
bp fragment, which constitutes the L49 construct, was also excised and purified. The 
vector and the L49 construct were ligated to obtain the L49 construct in pET-14b and 
transformed in E.coli BSJ cells.  
 
 
 
  λ  pET-14b  L49 
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4.1.1.2. DNA checking 
In order to check if the cloning process had been successful, 6 colonies were grown in 
LB medium. Their DNA was extracted and digested with Bgl II and Xho I restriction 
enzymes. Bgl II is present in pET-14b but absent in pProEx, so this digestion should 
provide further proof that the construct was successfully inserted in pET-14b. The 
digestion was expected to yield two fragments of 2007 bp and 4509 bp.  
Figure 7. Agarose gel with the L49 construct in pET-14b checked with Bgl II and Xho I. The far-left lane is, 
as always, the molecular marker λ DNA digested with BstEII. All the other lanes correspond to the DNAs extracted 
from each of the 6 colonies harboring the L49 construct inserted in pET14b. The agarose concentration was 1X 
and the gel was run for 40 minutes at 120 V. 
As shown in Figure 7, lanes 1 and 3 do not contain any DNA, probably because of 
mistakes committed during the DNA extraction. However, the rest of the checked 
DNAs presented the expected band pattern. The DNA corresponding to lane 2 was 
selected as the best one, because it contains a good quantity of DNA and seems to be 
clean. Thus, lane 2 DNA was used for the subsequent linker deletions. 
 
 
 
λ     1    2      3    4     5     6 
702 
1264 
1371 
1929 
2323 
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4.1.2. Linker deletions 
4.1.2.1. Digestions 
As previously explained, the length of the linker determines the efficiency of protein 
translational arrest. Thus, the DNA of the L49 construct in pET-14b was digested with 
different restriction enzymes to obtain constructs with linker lengths of 39 (L39), 33 
(L33), 26 (L26) and 21 (L21) residues. This produced two fragments in each digestion: 
a big fragment, of almost 6516 bp, and a very small fragment. The small fragments 
were 30 bp (L39), 48 bp (L33), 69 bp (L26) and 84 bp (L21) in length. Therefore, the 
big fragments were 6486 bp (L39), 6468 bp, (L33), 6447 bp (L26) and 6432 bp (L21) 
in length. 
Figure 8. Agarose gel with the digestions carried out to obtain constructs with different linker lengths. The 
agarose concentration was 1X and the gel was run for 40 minutes at 120 V. Lanes 2 to 5 show the constructs in 
which the linker has been digested to a final length of 21 (L21), 26 (L26), 33 (L33) and 39 (L39) residues. The 
restriction enzymes used for each deletion were the following: Sna BI/ Eco 72 I (L21), Sma I/ Eco 72I (L26), Sna 
BI/ Stu I (L33), Eco 72I (L39). 
As shown in Figure 8, the length differences are too low to be clearly appreciated. The 
gel should be run longer to observe them. The small fragments have too high 
electrophoretic mobility, and ran out of the gel. Two bands can be seen in L21, 
probably due to an incomplete digestion of the DNA.  
λ    L21  L26  L33 L39 
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The bands were excised from the gel and the DNA was purified for subsequent 
recircularization, giving rise to the constructs with different linker lengths in pET-14b. 
The DNA product was finally transformed in E.coli BSJ cells. Different colonies were 
grown in LB medium and their DNA was checked in order to be sure that linker 
digestions were performed properly. 
3.1.2.2. DNA checking 
The DNA checking was carried out with Bgl II and Xho I. The L49 construct was also 
digested in order to compare the five constructs. In each digestion, two fragments were 
obtained: a big fragment, 4509 bp long, and a smaller fragment around 2000 bp but 
with varying lengths. Those lengths were 2007 bp (L49), 1977 bp (L39), 1959 bp 
(L33), 1938 bp (L26) and 1923 bp (L21) (Figure 9). 
Figure 9. Agarose gel loaded with the constructs with different linker lengths, checked with Bgl II and Xho 
I. The agarose concentration was 1X and the gel was run for 50 minutes at 120 V. 
The constructs were successfully checked. However, the length differences are barely 
detectable. 
 
 
 
 
 λ   L39  L49 L33  L26 L21 
702 
1264 
1371 
1929 
2323 
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4.1.3. Sequencing 
In order to absolutely make sure that each linker length was successfully cloned, the 
constructs were sequenced. The sequencing was executed by the Secugen sequencing 
company.  
Figure 10. L33 construct in pET-14b sequencing result. 
Figure 10 shows the sequencing result of one of the constructs cloned in pET14-b. 
The first base pairs are commonly read poorly. From there onwards, a high-quality 
sequencing can be seen. The received sequences were compared with the expected 
sequences of the constructs. They all coincided, so the constructs had been successfully 
cloned in pET-14b. 
4.2. PROTEIN EXPRESSION 
4.2.1. Polyacrylamide gel 
In order to study protein expression of the five new constructs, each DNA was 
transformed in BL21(DE3)plysS. After gene expression and cell disruption, the 
soluble and insoluble fractions were separated by centrifugation and the soluble 
fractions were loaded in a 10% SDS-PAGE gel. Two samples were prepared for each 
construct, each of them extracted from two different bacterial colonies. After gel 
running, the gel was visualized in a VersaDoc 4000 (BioRad) imaging equipment. The 
mTFP1 fluorescent signal was detected upon excitation at 488 nm while mcpVenus173 
was excited at 555 nm. 
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Figure 11. Fluorescently excited polyacrylamide gel with the construct samples. Two independent samples 
were loaded for each construct length. Constructs containing linker lengths of 49 (L49; 1, 2),  39 (L39; 3, 4), 33 
(L33; 5, 6), 26 (L26; 7, 8) and 21 residues (L21; 9, 10)  are shown. A) Gel excited at 488 nm in order to excite 
mTFP1. B) Gel excited at 555 nm in order to excite mcpVenus173. 
The full-length and truncated protein bands are clearly observed and differentiated. On 
the one hand, full-length protein corresponds to the high molecular weight bands that 
can be seen in both Figure 11A and 11B, as they express mTFP1 and mcpVenus173. 
The presence of full-length protein indicates that the some of the AB helices have 
folded cotranslationally, generating a force that has relieved the stall produced by the 
arrest peptide. 
On the other hand, the truncated protein corresponds to the low molecular weight 
bands that can be observed just in Figure 11 A, since they expressed mTFP1 but not 
mcpVenus173 fluorescent protein. The presence of truncated protein means that some 
other AB helices have not been folded cotranslationally. Thus, the arrest peptide has 
stopped protein translation. 
As it can be seen in the image excited at 488 nm (Figure 11 A), the truncated bands 
have much more fluorescence intensity than the full-length ones. This means that most 
of the protein has been arrested during translation suggesting that most of it has not 
been folded in the ribosome vestibule.  
As a result of protein expression it was expected to obtain single full-length and 
truncated bands. However two full-length and three truncated bands are observed 
(Figure 11). It seems that the proteins could be somehow hydrolyzed into smaller 
peptides.  
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4.2.2. Fluorometric assay 
Besides analyzing protein expression by SDS-PAGE electrophoresis, the emission 
spectra of each construct were also analyzed. Samples were excited at 458 and 515 to 
excite mTFP1 and mcpVenus173 respectively.   
Figure 12. Emission spectra of the constructs containing different linker lengths. For each linker length, one 
of the two samples measured are represented, in order to make the figure clearer. A) Fluorescence emission when 
exciting mTFP1 at 458 nm. Samples were diluted so that the mTFP1 spectra coincided and differences in 
mcpVenus173 spectra could be clearly visible. B) Emission spectra when exciting mcpVenus173 at 515 nm.  
First, samples were diluted with buffer so that the mTFP1 fluorescent intensity was 
approximately the same in all of them (Figure 12A). As mTFP1 fluorescence accounts 
for both full-length and truncated proteins, dilution of all the samples to the same 
mTFP1 fluorescence value ensures that in all the cases the total protein amount will be 
almost the same and makes it easier to detect differences in full length expression. 
Knowing the total protein amount is equal, then mcpVenus173 emission was recorded 
(Figure 12B), in order to determine the full-length protein fraction.   
As shown in Figure 12B, L39 is the linker length with the highest mcpVenus173 
fluorescence. Therefore, this is the construct in which there is more full-length protein, 
and there has been less arrest. It is the construct in which the folding of the helices has 
exerted most force in order to relieve the stall of the translation. 
As it can be seen in Figure 12, the fluorescence intensity is much higher when exciting 
mTFP1 than when exciting mcpVenus173. This coincides with the fact that in Figure 
11A the truncated bands had much more intensity than the full-length ones. To have 
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an idea about the amount of full-length protein translated, the full-length/total protein 
ratio was calculated by dividing the mcpVenus173 emission maximum at 528 nm by 
the mTFP1 emission maximum at 492 nm.  
The mcpVenus173/mTFP1 ratio yielded the following results: 
 
Figure 13. mcpVenus173/mTFP1 ratio for each protein construct. The relative amount of full-length protein 
was expressed as the mcpVenus173/mTFP1 ratio. The ratio of constructs containing linker lengths of 49 (L49; 
red), 39 (L39; black), 33 (L33; blue), 26 (L26; green), and 21 residues (L21; brown) are shown. Two different 
samples were analyzed for each construct. 
As can be observed in Figure 13, the results are quite reproducible taking into account 
that the two different samples measured for each construct give similar results, except 
for L26. There is a high discrepancy between L26(7) and L26(8) samples. The 
expression of this construct should be repeated, but due to time limitations this was 
not possible. 
As had already been noted in Figure 12, Figure 13 shows that the 
mcpVenus173/mTFP1 ratio is highest in the L39 construct. It seems that in constructs 
containing linkers of 49 residues (L49) there is considerable arrest, L39 is the construct 
in which there is least arrest, and with shorter linker lengths there is gradually more 
arrest. L26(8) breaks this tendency, but I think that the discrepancy in this sample was 
caused by an experimental mistake during the procedure. 
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5. DISCUSSION 
The use of arrest peptides (AP) is a relatively new technique (Ismail et. al., 2012) that 
overcomes the limitations of in vitro methods, since it allows the study of 
cotranslational folding in vivo. In this work, AP were employed to study the 
cotranslational folding of the cytosolic AB helices of the potassium channel Kv7.2. 
Mutations in this channel have been related to serious epileptic diseases. Some of them 
could be caused by a pathogenic cotranslational folding of the channel, as it has been 
hypothesized for the W344R A helix mutant. 
In this work, constructs were used in which the AB helices are separated from the 
arrest peptide by a linker of variable length, because the distance between the point in 
which folding takes place and the arrest peptide is a crucial parameter to study the 
cotranslational folding. In addition, in order to detect the full-length and truncated 
protein, fluorescent proteins mTFP1 and mcpVenus173 were placed in the N-terminus 
and C-terminus respectively. The presence of mcpVenus173 will indicate the 
production of full-length protein, which means that the protein has folded 
cotranslationally, relieving the stall produced by the arrest peptide. 
Once the constructs were successfully cloned in a pET vector, which allows a better 
regulation of protein synthesis, the expression of the different proteins was analyzed 
by SDS-PAGE. Figure 11 shows that both full-length and truncated proteins are 
somehow hydrolyzed into smaller peptides. The cause of this fracture is unclear. It 
could happen during translation or after translation, due to sample manipulation. 
As it was expected, the fluorophores permit a good detection of the full-length and 
truncated protein by electrophoresis (Figure 11). Most of the protein was synthesized 
as the truncated form, suggesting that in the tested conditions most of the protein does 
not cotranslationally fold in the ribosome vestibule and does not generate enough force 
to relieve the stall. The fluorometric assays support this hypothesis, as in all the 
constructs the fluorescence emitted when exciting mcpVenus173 was much lower than 
the one emitted when exciting mTFP1 (Figure 12). 
The full-length/total protein ratio, calculated as the fluorescence of 
mcpVenus173/mTFP1, indicates that the linker with which most full-length protein is 
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produced is 39 residues long (Figure 13). According to Voss et. al. (2006), the 
ribosome exit tunnel can accommodate between 30 and 40 residues. Thus, a possible 
explanation for this result is that the L39 linker enables helix B to come out of the 
ribosome at the point in which the arrest peptide interacts with the ribosome exit 
tunnel, allowing the AB helices to slightly fold and relieve some of the arrest. 
The L39 linker length being the one which most favors cotranslational folding is 
perfectly concordant with recent literature. Goldman et. al. (2015) describe that in the 
cotranslational folding of Top7, linker lengths of 31-38 residues are the ones which 
produce most full-length protein, which is quite close to the 39 residue-long linker 
reported in this work. Even more interestingly, Farias-Rico et. al. (2018) analyze the 
cotranslational folding of proteins of different size. They conclude that the protein size 
is crucial for the impact of the linker length. From the tested proteins, Calmodulin 
EF2-EF3 is the one which is closest in length to the AB helices (60 residues of 
Calmodulin EF2-EF3 compared to 70 residues of the AB helices). In that case, the 
linker length of 40 residues proved to be the one which produced most full-length 
protein, again very close to the 39 residues indicated in this project. 
However, in this work, the observed differences between linker lengths are too low to 
reach an absolute conclusion about which linker length allows the most efficient 
cotranslational folding. Indeed, the full-length protein fraction is very scarce, which 
could contribute to making it difficult to detect the differences in linker length. There 
can be two reasons for the low full-protein production:  
1) The employed arrest peptide is probably too efficient. Its interaction with the 
ribosome exit tunnel might be very strong, hence a poor full-length protein fraction is 
produced, making it problematic to observe differences between linker lengths.  
2) It is possible that the presence of regulator molecules that physiologically interact 
with the helices will be required to promote the cotranslational folding. Calmodulin is 
essential for the good functioning of the channel and has been shown to help in channel 
trafficking to the membrane (Alaimo et. al., 2009). Thus, it would be interesting to 
study if Calmodulin will help in cotranslational folding as well. 
Future steps to continue this work would try to improve those two areas. On the one 
hand, less efficient arrest peptides might be tried, so that more full-length protein is 
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produced and differences between linker lengths are more visible. In this direction, 
Cymer et. al. (2015) showed that there are key residues in the arrest peptide sequence. 
By mutating those residues, they obtained arrest peptides with different arrest 
efficiency. Thus, by modifying certain amino acids of the arrest peptide sequence, less 
efficient arrest peptides could be obtained, which would probably be more useful in 
this project. 
On the other hand, the effect of Kv7.2 regulator molecules, including Calmodulin, on 
protein expression should be studied in order to determine if they are implicated in the 
cotranslational folding of the helices. 
In any case, the results obtained in this project show the potential of the arrest peptides 
in the study of in vivo cotranslational folding, in conditions much closer to the 
physiological ones than in vitro experiments. This method, combined with the use of 
fluorescent proteins, permits the study of cotranslational folding without the need to 
purify the protein, which makes the technique very time and cost-effective. It can be 
used to study the cotranslational folding of different small protein domains, and thus 
offers great possibilities to analyze the effect of pathogenic mutations on protein 
folding. 
6. CONCLUSIONS 
- The results show that arrest peptides, in combination with fluorescent proteins, are a 
powerful tool to study cotranslational folding in vivo, interestingly without the need to 
purify the protein. 
- In the tested conditions, most of the AB helices do not fold cotranslationally in the 
ribosome vestibule. Although linker lengths of 39 residues appear to be the most 
adequate ones to detect protein folding, in future projects, a less stringent arrest peptide 
or protein co-expression with Calmodulin might be tried to find conditions that favor 
protein folding. 
7. BIBLIOGRAPHY 
Alaimo, A., Gómez-Posada, J. C., Aivar, P., Etxeberría, A., Rodriguez-Alfaro, J. A., 
Areso, P., & Villarroel, A. 2009. Calmodulin activation limits the rate of KCNQ2 K+ 
24 
 
channel exit from the endoplasmic reticulum. Journal of Biological Chemistry, 284: 
20668-20675. 
Bernardo-Seisdedos, G., Nuñez, E., Gomis-Perez, C., Malo, C., Villarroel, Á., & 
Millet, O. 2018. Structural basis and energy landscape for the Ca2+ gating and 
calmodulation of the Kv7. 2 K+ channel. Proceedings of the National Academy of 
Sciences, 115: 2395-2400. 
Butkus, M. E., Prundeanu, L. B., & Oliver, D. B. 2003. Translocon “pulling” of 
nascent SecM controls the duration of its translational pause and secretion-responsive 
secA regulation. Journal of bacteriology, 185: 6719-6722. 
Chung, H. J. 2014. Role of calmodulin in neuronal Kv7/KCNQ potassium channels 
and epilepsy. Frontiers in biology, 9: 205-215. 
Cymer, F., & von Heijne, G. 2013. Cotranslational folding of membrane proteins 
probed by arrest-peptide–mediated force measurements. Proceedings of the National 
Academy of Sciences, 110: 14640-14645. 
Cymer, F., Hedman, R., Ismail, N., & von Heijne, G. 2015. Exploration of the arrest 
peptide sequence space reveals arrest-enhanced variants. Journal of Biological 
Chemistry, 290: 10208-10215. 
Farias-Rico, J. A., Selin, F. R., Myronidi, I., Frühauf, M., & Von Heijne, G. 2018. 
Effects of protein size, thermodynamic stability, and net charge on cotranslational 
folding on the ribosome. Proceedings of the National Academy of Sciences, 115: 9280-
9287. 
Goldberg-Stern, H., Kaufmann, R., Kivity, S., Afawi, Z., & Heron, S. 2009. Novel 
Mutation in KCNQ2 Causing Benign Familial Neonatal Seizures. Pediatric 
Neurology, 41: 367-370. 
Goldman, D. H., Kaiser, C. M., Milin, A., Righini, M., Tinoco, I., & Bustamante, C. 
2015. Mechanical force releases nascent chain–mediated ribosome arrest in vitro and 
in vivo. Science, 348: 457-460. 
Ismail, N., Hedman, R., Schiller, N., & Von Heijne, G. 2012. A biphasic pulling force 
acts on transmembrane helices during translocon-mediated membrane 
integration. Nature structural & molecular biology, 19: 1018. 
25 
 
Madden, T. 2002. The BLAST Sequence Analysis Tool. 2002 Oct 9 [Updated 2003 
Aug 13]. The NCBI Handbook [Internet]. Bethesda (MD): National Center for 
Biotechnology Information (US). 
Merck webpage. Available at: https://www.merck.com/   Accessed 10/06/2019. 
Nakatogawa, H., & Ito, K. 2001. Secretion monitor, SecM, undergoes self-translation 
arrest in the cytosol. Molecular cell, 7: 185-192. 
Neubauer, B. A., Waldegger, S., Heinzinger, J., Hahn, A., Kurlemann, G., Fiedler, B., 
Eberhard, F., Muhle, H., Stephani, U., Garkisch, S. & Eeg-Olofsson, O. 2008. KCNQ2 
and KCNQ3 mutations contribute to different idiopathic epilepsy 
syndromes. Neurology, 71: 177-183. 
Otto, J. F., Yang, Y., Frankel, W. N., White, H. S., & Wilcox, K. S. 2006. A 
spontaneous mutation involving Kcnq2 (Kv7. 2) reduces M-current density and spike 
frequency adaptation in mouse CA1 neurons. Journal of Neuroscience, 26: 2053-
2059. 
SibEnzyme webpage. Available at: sibenzyme.com/   Accessed 10/06/2019. 
Voss, N. R., Gerstein, M., Steitz, T. A., & Moore, P. B. 2006. The geometry of the 
ribosomal polypeptide exit tunnel. Journal of molecular biology, 360: 893-906. 
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R., 
Deprez, L., Smets, K., Hristova, D., & Jordanova, A. 2012. KCNQ2 encephalopathy: 
emerging phenotype of a neonatal epileptic encephalopathy. Annals of neurology, 71: 
15-25. 
Zhang, J., Pan, X., Yan, K., Sun, S., Gao, N., & Sui, S. F. 2015. Mechanisms of 
ribosome stalling by SecM at multiple elongation steps. elife, 4: e09684. 
 
